Xuehong Deng

961 total citations
22 papers, 773 citations indexed

About

Xuehong Deng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xuehong Deng has authored 22 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Xuehong Deng's work include Prostate Cancer Treatment and Research (6 papers), Epigenetics and DNA Methylation (5 papers) and Cancer-related gene regulation (5 papers). Xuehong Deng is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Epigenetics and DNA Methylation (5 papers) and Cancer-related gene regulation (5 papers). Xuehong Deng collaborates with scholars based in United States, China and United Kingdom. Xuehong Deng's co-authors include Chang‐Deng Hu, Y. John Shyu, Han Liu, Han Liu, Jiaoti Huang, Jian Jian Li, Elizabeth J. Taparowsky, Chang-Deng Hu, Sarah J. Parsons and Liang Cheng and has published in prestigious journals such as The EMBO Journal, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Xuehong Deng

20 papers receiving 761 citations

Peers

Xuehong Deng
Comparison fields: 5 of 81
  • Molecular Biology 561
  • Pulmonary and Respiratory Medicine 118
  • Oncology 102
  • Biophysics 84
  • Cell Biology 82
Replace Silvia Kocanova with:
Silvia Kocanova France
Xiaomeng Hou China
Catherine Le Jossic-Corcos France
Takeshi Mizuno Japan
Teneale A. Stewart Australia
Jing Niu China
Shengchen Lin China
Ludovic D’Auria Belgium
Boon Tin Chua Singapore
John P. Miller United States
Silvia Kocanova France View profile →
Citations per field, relative to Xuehong Deng
Xuehong Deng · 1×
Citations per year, relative to Xuehong Deng
Xuehong Deng · 1×

Countries citing papers authored by Xuehong Deng

Since Specialization
Citations

This map shows the geographic impact of Xuehong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuehong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuehong Deng more than expected).

Fields of papers citing papers by Xuehong Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuehong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuehong Deng. The network helps show where Xuehong Deng may publish in the future.

Co-authorship network of co-authors of Xuehong Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Xuehong Deng. A scholar is included among the top collaborators of Xuehong Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuehong Deng. Xuehong Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 5
3 7
4 28
5 38
6 6
7 26
8
Cotargeting of Androgen Synthesis and Androgen Receptor Expression as a Novel Treatment for Castration-Resistant Prostate Cancer
0
9 6
10
[Research progress in epigenetic regulation of myocardial ischemia/ reperfusion injury by traditional Chinese medicine].
0
11 11
12 8
13 1
14
Targeting CREB inhibits radiation-induced neuroendocrine differentiation and increases radiation-induced cell death in prostate cancer cells.
32
15 9
16 13
17
Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patients.
45
18 90
19 93
20 336

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026